Carregant...
Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer
BACKGROUND: There has been considerable development in the treatment of advanced prostate cancer over the last decade. A number of agents, including docetaxel, cabazitaxel, abiraterone acetate, enzalutamide and sipuleucel‐T, have been reported to improve outcomes in men with castration‐resistant dis...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2018
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516883/ https://ncbi.nlm.nih.gov/pubmed/30320443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012816.pub2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|